SK
Sanjay Krishnaji Raut
About Sanjay Krishnaji Raut
Data last updated:
Sanjay Krishnaji Raut has 18 years in corporate governance. Holds Director and Designated Partner roles. Currently with 3 companies, including Phaltan Lifeline Hospital Private Limited and Brewster Pharma Private Limited. Formerly with 2 companies, such as Lifeline Hospital & Healthcare Services Private Limited and Abhinav Mri & Diagnostics Private Limited. Engaged in General Business, Healthcare.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
| Director | 25 Sep 2014 | 2014 | Active | |
| Director | 17 Jan 2022 | 2017 | Active | |
| Designated Partner | 17 Jul 2026 | 2026 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
| Director | 05 Jun 2008 | 2008 | Strike Off | |
| Whole-Time Director | 10 Dec 2014 | 2010 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sanjay Krishnaji Raut
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanjay Krishnaji Raut
Sanjay Krishnaji Raut has 18 years in corporate governance. Holds Director and Designated Partner roles. Currently with 3 companies, including Phaltan Lifeline Hospital Private Limited and Brewster Pharma Private Limited. Formerly with 2 companies, such as Lifeline Hospital & Healthcare Services Private Limited and Abhinav Mri & Diagnostics Private Limited. Engaged in General Business, Healthcare.
Sanjay Krishnaji Raut is associated with 3 companies as Director and Designated Partner.
Sanjay Krishnaji Raut has expertise in General Business, Healthcare.
Sanjay Krishnaji Raut has 18 years in corporate governance.